Metastatic breast cancer is often treated as a series of steps, one approach after another. When your oncologist says the standard steps are running out, it is natural to wonder what else might be worth discussing. The answer depends heavily on the subtype of your breast cancer, such as hormone receptor status and HER2 status, and whether those markers have changed over time.
This guide explains the questions worth bringing to your oncologist, when a second opinion can help, and how the FDA’s pre-approval pathways work, so you can approach the next conversation with more confidence.
What to ask your oncologist
Questions specific to breast cancer:
- What is the current hormone receptor and HER2 status of my cancer, and should a new biopsy re-check it?
- Has my tumor had genomic testing, and could the results point to approved options we have not tried?
- Have we considered every approved option for my breast cancer subtype?
- Could radiation or another local treatment help with specific sites, such as bone or brain metastases?
- How can we best manage side effects and protect my quality of life going forward?
Questions worth asking for any advanced cancer:
- What are the goals of treatment from here: control, symptom relief, or comfort?
- Are there any approved options we have not yet discussed, including ones used off-label?
- Would you support me getting a second opinion, and who would you recommend?
- Would a pre-approval pathway such as expanded access or Right to Try be worth discussing for me?
- Can we bring in palliative and supportive care now, alongside any other treatment?
